Cargando…
Pure red cell aplasia induced by epoetin zeta
Pure red cell aplasia (PRCA) may develop in patients with chronic kidney disease receiving erythropoiesis-stimulating agents (ESA). We report on a 72-year-old patient who developed hypo-proliferative anaemia unresponsive to ESA following the administration of epoetin zeta subcutaneously for 7 months...
Autores principales: | Panichi, Vincenzo, Ricchiuti, Guido, Scatena, Alessia, Del Vecchio, Lucia, Locatelli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957714/ https://www.ncbi.nlm.nih.gov/pubmed/27478604 http://dx.doi.org/10.1093/ckj/sfw030 |
Ejemplares similares
-
Post renal transplant pure red cell aplasia—is tacrolimus a culprit?
por: Patil, Malagouda R., et al.
Publicado: (2016) -
Desarrollo de un puré instantáneo a base de malanga
por: Viveros, Efrain Calleja, et al.
Publicado: (2021) -
Pure red cell aplasia after treatment of renal anaemia with epoetin theta
por: Herrington, W., et al.
Publicado: (2013) -
Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia
por: Mahajan, S. A., et al.
Publicado: (2015) -
Resolution of epoetin‐induced pure red cell aplasia, successful re‐challenge with roxadustat
por: Wu, Yunzhou, et al.
Publicado: (2020)